Suppr超能文献

Fcγ受体对IgG的识别。Fc糖基化的作用及肽抑制剂的结合

Recognition of IgG by Fcgamma receptor. The role of Fc glycosylation and the binding of peptide inhibitors.

作者信息

Radaev S, Sun P D

机构信息

Structural Biology Section, Laboratory of Immunogenetics, NIAID, National Institutes of Health, Rockville, Maryland 20852, USA.

出版信息

J Biol Chem. 2001 May 11;276(19):16478-83. doi: 10.1074/jbc.M100351200. Epub 2001 Jan 31.

Abstract

Recently determined crystal structures of the complex between immunoglobulin constant regions (Fc) and their Fc-respective receptors (FcR) have revealed the detailed molecular interactions of this receptor-ligand pair. Of particular interest is the contribution of a glycosylation at Asn(297) of the C(H)2 domain of IgG to receptor recognition. The carbohydrate moieties are found outside the receptor.Fc interface in all receptor.Fc complex structures. To understand the role of glycosylation in FcR recognition, the receptor affinities of a deglycosylated IgG1 and its Fc fragment were determined by solution binding studies using surface plasmon resonance. The removal of carbohydrates resulted in a non-detectable receptor binding to the Fc alone and a 15- to 20-fold reduction of the receptor binding to IgG1, suggesting that the carbohydrates are important in the function of the FcgammaRIII. Structurally, the carbohydrates attached to Asn(297) fill the cavity between the C(H)2 domains of Fc functioning equivalently as a hydrophobic core. This may stabilize a favorable lower hinge conformation for the receptor binding. The structure of the complex also revealed the dominance of the lower hinge region in receptor.Fc recognition. To evaluate the potential of designing small molecular ligands to inhibit the receptor function, four lower hinge peptides were investigated for their ability to bind to the receptor FcgammaRIII. These peptides bind specifically to FcgammaRIII with affinities 20- to 100-fold lower than IgG1 and are able to compete with Fc in receptor binding. The results of peptide binding illustrate new ways of designing therapeutic compounds to block Fc receptor activation.

摘要

最近确定的免疫球蛋白恒定区(Fc)与其各自的Fc受体(FcR)之间复合物的晶体结构揭示了这一受体-配体对的详细分子相互作用。特别令人感兴趣的是IgG的C(H)2结构域中Asn(297)位点的糖基化对受体识别的贡献。在所有受体-Fc复合物结构中,碳水化合物部分位于受体-Fc界面之外。为了了解糖基化在FcR识别中的作用,通过表面等离子体共振的溶液结合研究确定了去糖基化IgG1及其Fc片段与受体的亲和力。去除碳水化合物导致单独的Fc无法检测到受体结合,并且与IgG1的受体结合减少了15至20倍,这表明碳水化合物对FcγRIII的功能很重要。在结构上,连接到Asn(297)的碳水化合物填充了Fc的C(H)2结构域之间的空腔,起到了等效于疏水核心的作用。这可能稳定了有利于受体结合的较低铰链构象。复合物的结构还揭示了较低铰链区在受体-Fc识别中的主导作用。为了评估设计小分子配体以抑制受体功能的潜力,研究了四种较低铰链肽与受体FcγRIII结合的能力。这些肽特异性结合FcγRIII,亲和力比IgG1低20至100倍,并且能够在受体结合中与Fc竞争。肽结合的结果说明了设计治疗性化合物以阻断Fc受体激活的新方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验